Antoine Nougairede

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Rapid differentiation of VLA1553 and wild-type ECSA chikungunya strains in the context of an IXCHIQ vaccination campaign.

Rapid differentiation of VLA1553 and wild-type ECSA chikungunya strains in the context of an IXCHIQ vaccination campaign.

Journal: Emerging microbes & infections

Published: May 13, 2026

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

Journal: The Journal of antimicrobial chemotherapy

Published: February 15, 2026

In Vitro and In Vivo Models for Drug Development Against Two Hemorrhagic Hareavirales: Rift Valley Fever and Crimean Congo Hemorrhagic Fever Viruses.

In Vitro and In Vivo Models for Drug Development Against Two Hemorrhagic Hareavirales: Rift Valley Fever and Crimean Congo Hemorrhagic Fever Viruses.

Journal: Viruses

Published: February 10, 2026

Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.

Preclinical efficacy of a favipiravir and nitazoxanide combination against Rift Valley Fever Virus.

Journal: Antiviral research

Published: January 27, 2026

Modulating Chikungunya and Mayaro virus-induced disease severity in mice using low concentrations of anti-IFNAR1 antibodies.

Modulating Chikungunya and Mayaro virus-induced disease severity in mice using low concentrations of anti-IFNAR1 antibodies.

Journal: Emerging microbes & infections

Published: January 14, 2026

Serological diagnosis of chronic skin granulomas caused by wild-type or vaccine-derived rubella virus in patients with inherited HLA class I deficiency.

Serological diagnosis of chronic skin granulomas caused by wild-type or vaccine-derived rubella virus in patients with inherited HLA class I deficiency.

Journal: Journal of human immunity

Published: January 14, 2026

De novo generation of viruses in animals: from infection models to vaccine development.

De novo generation of viruses in animals: from infection models to vaccine development.

Journal: mSphere

Published: August 11, 2025

Development and evaluation of a duplex RT-qPCR assay for the detection and identification of Mayaro and chikungunya viruses.

Development and evaluation of a duplex RT-qPCR assay for the detection and identification of Mayaro and chikungunya viruses.

Journal: Journal of clinical microbiology

Published: July 03, 2025

Virological characterization of SARS-CoV-2 BA.2.86 variants by assessing antiviral susceptibility, in vivo infectivity and replicative fitness.

Virological characterization of SARS-CoV-2 BA.2.86 variants by assessing antiviral susceptibility, in vivo infectivity and replicative fitness.

Journal: Scientific reports

Published: June 24, 2025

Nine autochthonous cases of Toscana virus infection in France, 2022-2024: a clinical and virological overview.

Nine autochthonous cases of Toscana virus infection in France, 2022-2024: a clinical and virological overview.

Journal: Journal of travel medicine

Published: May 14, 2025

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

Journal: Clinical and translational science

Published: May 12, 2025

Assessing human liver spheroids as a model for antiviral drug evaluation against BSL-3 haemorrhagic fever viruses.

Assessing human liver spheroids as a model for antiviral drug evaluation against BSL-3 haemorrhagic fever viruses.

Journal: Antiviral research

Published: January 29, 2025

Showing 1-12 of 104

Last Updated: 09/26/2026